Monopar Therapeutics
MNPR
#7537
Rank
C$0.67 B
Marketcap
C$98.95
Share price
-1.84%
Change (1 day)
-23.36%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -C$24.87 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$19.68 Million, an increase over its 2024 earnings that were of -C$22.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$24.87 Million26.42%
2025 -C$19.68 Million-11.99%
2024 -C$22.36 Million85.5%
2023 -C$12.05 Million-20.1%
2022 -C$15.09 Million15.52%
2021 -C$13.06 Million44.39%
2020 -C$9.05 Million49.23%
2019 -C$6.06 Million28.04%
2018 -C$4.74 Million-80.07%
2017 -C$23.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA